The latest board meeting for Xilio Therapeutics Inc took place on 18 Mar 2026, for the purpose of Xilio Therapeutics Inc Annual Report for 2025See details
Xilio Therapeutics Inc has a share price target of , revenue growth forecast of 620.0%, and profit growth estimate of 26.0% for FY25, based on top 1 analyst call.